2023.12 - Pharmasaga Officially Initiates Phase I Clinical Trial
12/01/2023
Pharmasaga officially initiated its Phase I clinical trial in December 2023, following dual approval from the Taiwan Food and Drug Administration (TFDA) and the U.S. Food and Drug Administration (USFDA).
